A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Organon & Co. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 69,412 shares of OGN stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,412
Previous 73,460 5.51%
Holding current value
$1.06 Million
Previous $1.52 Million 12.7%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $75,495 - $93,225
-4,048 Reduced 5.51%
69,412 $1.33 Million
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $1.28 Million - $1.61 Million
73,460 New
73,460 $1.52 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.